iSpecimen Inc.

NasdaqCM ISPC

iSpecimen Inc. Total Non-Current Liabilities for the quarter ending September 30, 2024: USD 281.44 K

iSpecimen Inc. Total Non-Current Liabilities is USD 281.44 K for the quarter ending September 30, 2024, a 289.33% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • iSpecimen Inc. Total Non-Current Liabilities for the quarter ending September 30, 2023 was USD 72.29 K, a -97.31% change year over year.
  • iSpecimen Inc. Total Non-Current Liabilities for the quarter ending September 30, 2022 was USD 2.68 M, a -21.74% change year over year.
  • iSpecimen Inc. Total Non-Current Liabilities for the quarter ending September 30, 2021 was USD 3.43 M, a -70.14% change year over year.
  • iSpecimen Inc. Total Non-Current Liabilities for the quarter ending September 30, 2020 was USD 11.48 M.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
NasdaqCM: ISPC

iSpecimen Inc.

CEO Ms. Leslie Hoyt
IPO Date June 17, 2021
Location United States
Headquarters 450 Bedford Street
Employees 53
Sector Health Care
Industries
Description

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Similar companies

XGN

Exagen Inc.

USD 3.00

-3.85%

PSNL

Personalis, Inc.

USD 5.13

-4.11%

FONR

FONAR Corporation

USD 15.16

0.20%

CSTL

Castle Biosciences, Inc.

USD 25.46

-2.64%

OCX

OncoCyte Corporation

USD 2.15

3.36%

INBS

Intelligent Bio Solutions Inc.

USD 1.30

-1.52%

StockViz Staff

January 16, 2025

Any question? Send us an email